What Reckitt’s $1.4 Billion Settlement Says About The Pharma Industry |
July 18, 2019 | July 2019 Bond Updates |
Making misleading claims about the safety and effectiveness of drugs to convince doctors to write more prescriptions has long been one of the pharmaceutical industry’s favored methods of driving profits. |
View more at: https://www.forbes.com/sites/erikakelton/2019/07/17/what-reckitts-14-billion-settlement-says-about-the-pharma-industry/ |
Related News |
|